tobramycin has been researched along with diclofenac in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Andreu, D; Costa, J; Martínez, M; Notivol, R; Salvá, P | 1 |
| Güler, C; Irkeç, M; Kayikçioglu, O; Kir, E; Söyler, M | 1 |
| Alió y Sanz, J; Honrubia López, FM; Ruiz Moreno, JM; Ruiz Moreno, O; Vélez, P | 1 |
| Caspers-Valu, LE; Dumont, P; Vandorselaer, T; Vauthier, L; Youssfi, H | 1 |
| Gallardo Galera, JM | 1 |
| Doblinger, A; Fischer-Colbrie, R; Kieselbach, G; Kirchmair, R; Kralinger, M; Pallhuber, J; Stemberger, K; Troger, J | 1 |
| Ornek, K; Ozdemir, O; Yalçindağ, FN | 1 |
| Ares-Mazas, E; Caccio, SM; Darwich, L; Gomez-Couso, H; Leiva, M; Martin-Vazquez, S; Molina-Lopez, RA; Ramis, A | 1 |
| Coco, RM; Fernández, I; Fernández-Muñoz, M; Galindo, A; Losada, MV; Montero, JA; Sampedro, A; Sanabria, MR | 1 |
| Hosseini, M; Marasini, N; Sheikh, Z; Spicer, PT; Traini, D; Wong, CYJ; Xin Ong, H; Young, P | 1 |
2 trial(s) available for tobramycin and diclofenac
| Article | Year |
|---|---|
Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
Topics: Adolescent; Adult; Conjunctiva; Cross-Over Studies; Diclofenac; Double-Blind Method; Drug Combinations; Eye Injuries; Female; Fluorescein; Humans; Hyperemia; Intraocular Pressure; Irritants; Male; Middle Aged; Ophthalmic Solutions; Retina; Tobramycin; Visual Acuity | 1999 |
Ocular pain after intravitreal injection.
Topics: Aged; Aged, 80 and over; Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Eye Pain; Female; Humans; Intravitreal Injections; Lidocaine; Male; Middle Aged; Naphazoline; Nasal Decongestants; Prospective Studies; Ranibizumab; Retinal Diseases; Tetracaine; Tobramycin | 2013 |
16 other study(ies) available for tobramycin and diclofenac
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Ocular findings in a measles epidemic among young adults.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctiva; Conjunctivitis; Corneal Diseases; Diclofenac; Disease Outbreaks; Eye Hemorrhage; Humans; Keratitis; Male; Measles; Ophthalmic Solutions; Tobramycin; Turkey; Visual Acuity | 2000 |
[Effect of tobramycin with topical diclofenac on arachidonic acid in endotoxin-induced uveitis].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Bacterial Toxins; Diclofenac; Dinoprostone; Drug Interactions; Drug Therapy, Combination; Endotoxins; Leukotriene B4; Rabbits; Tobramycin; Uveitis | 2001 |
[Treatment of traumatic corneal abrasion with contact lens associated with topical nonsteroid anti-inflammatory agent (NSAID) and antibiotic: a safe, effective and comfortable solution].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Contact Lenses; Corneal Injuries; Diclofenac; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tobramycin; Wounds and Injuries | 2001 |
[Drug therapy combinations].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Interactions; Drug Therapy, Combination; Humans; Research Support as Topic; Tobramycin | 2002 |
Secretoneurin in the human aqueous humor and the absence of an effect of frequently used eye drops on the levels.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Cyclosporine; Diclofenac; Drug Combinations; Female; Humans; Male; Middle Aged; Neuropeptides; Ophthalmic Solutions; Pregnadienes; Secretogranin II; Tobramycin; Uveitis, Anterior | 2004 |
Corneal melting associated with a fixed-dose combination of diclofenac 0.1% plus tobramycin 0.3% following cataract surgery.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Corneal Diseases; Diclofenac; Drug Combinations; Female; Humans; Tobramycin | 2008 |
Cryptosporidium baileyi infection associated with an outbreak of ocular and respiratory disease in otus owls (Otus scops) in a rehabilitation centre.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blepharoptosis; Conjunctivitis; Corneal Diseases; Cryptosporidiosis; Cryptosporidium; Diclofenac; Disease Outbreaks; Edema; Enrofloxacin; Euthanasia; Eyelid Diseases; Fluoroquinolones; Raptors; Strigiformes; Tobramycin | 2010 |
Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
Topics: Administration, Inhalation; Cystic Fibrosis; Diclofenac; Dry Powder Inhalers; Excipients; Humans; Particle Size; Powders; Respiratory Aerosols and Droplets; Tobramycin | 2022 |